226 related articles for article (PubMed ID: 36936916)
1. Identification of a necroptosis-related gene signature as a novel prognostic biomarker of cholangiocarcinoma.
Xu L; Gao X; Xing J; Guo Z
Front Immunol; 2023; 14():1118816. PubMed ID: 36936916
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma.
Sun K; Hong JJ; Chen DM; Luo ZX; Li JZ
BMC Gastroenterol; 2022 Jul; 22(1):344. PubMed ID: 35840882
[TBL] [Abstract][Full Text] [Related]
3. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
Sun K; Huang C; Li JZ; Luo ZX
World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel mutation gene signature HAMP for cholangiocarcinoma through comprehensive TCGA and GEO data mining.
Wang Z; Du Y
Int Immunopharmacol; 2021 Oct; 99():108039. PubMed ID: 34426102
[TBL] [Abstract][Full Text] [Related]
5. Exploration and validation of a novel signature of seven necroptosis-related genes to improve the clinical outcome of hepatocellular carcinoma.
Tao Q; Lang Z; Li Y; Gao Y; Lin L; Yu Z; Zheng J; Yu S
BMC Cancer; 2023 Oct; 23(1):1029. PubMed ID: 37875823
[TBL] [Abstract][Full Text] [Related]
6. Construction and validation of a prognostic signature based on necroptosis-related genes in hepatocellular carcinoma.
Peng YL; Wang LX; Li MY; Liu LP; Li RS
PLoS One; 2023; 18(2):e0279744. PubMed ID: 36795724
[TBL] [Abstract][Full Text] [Related]
7. A Novel Prognostic Predictor of Immune Microenvironment and Therapeutic Response in Kidney Renal Clear Cell Carcinoma based on Necroptosis-related Gene Signature.
Chen W; Lin W; Wu L; Xu A; Liu C; Huang P
Int J Med Sci; 2022; 19(2):377-392. PubMed ID: 35165523
[No Abstract] [Full Text] [Related]
8. Identification of Prognostic Factors in Cholangiocarcinoma Based on Integrated ceRNA Network Analysis.
Jin H; Liu W; Xu W; Zhou L; Luo H; Xu C; Chen X; Chen W
Comput Math Methods Med; 2022; 2022():7102736. PubMed ID: 36158120
[TBL] [Abstract][Full Text] [Related]
9. Potential prognosis index for m
Zhu H; Zhao H; Wang J; Zhao S; Ma C; Wang D; Gao H; Yang F; Ni Q; Li H; Zhou X; Zhang C; Lu J
BMC Cancer; 2022 Jun; 22(1):620. PubMed ID: 35672673
[TBL] [Abstract][Full Text] [Related]
10. An Efficient Signature Based on Necroptosis-Related Genes for Prognosis of Patients With Pancreatic Cancer.
Shi H; Peng Q; Zhou X; He Y; Sun S
Front Genet; 2022; 13():848747. PubMed ID: 35419022
[TBL] [Abstract][Full Text] [Related]
11. Identification and Validation of Prognostic Model for Pancreatic Ductal Adenocarcinoma Based on Necroptosis-Related Genes.
Xie H; Xu J; Xie Z; Xie N; Lu J; Yu L; Li B; Cheng L
Front Genet; 2022; 13():919638. PubMed ID: 35783277
[No Abstract] [Full Text] [Related]
12. Identification of a necroptosis-related gene signature for making clinical predictions of the survival of patients with lung adenocarcinoma.
Zhou X; Zhao M; Fan Y; Xu Y
PeerJ; 2024; 12():e16616. PubMed ID: 38213773
[TBL] [Abstract][Full Text] [Related]
13. Development of a necroptosis-related gene signature and the immune landscape in ovarian cancer.
Nie S; Ni N; Chen N; Gong M; Feng E; Liu J; Liu Q
J Ovarian Res; 2023 Apr; 16(1):82. PubMed ID: 37095524
[TBL] [Abstract][Full Text] [Related]
14. ACSL4 serves as a novel prognostic biomarker correlated with immune infiltration in Cholangiocarcinoma.
Liu S; Fan S; Wang Y; Chen R; Wang Z; Zhang Y; Jiang W; Chen Y; Xu X; Yu Y; Li C; Li X
BMC Cancer; 2023 May; 23(1):444. PubMed ID: 37193981
[TBL] [Abstract][Full Text] [Related]
15. A metabolism-related 4-lncRNA prognostic signature and corresponding mechanisms in intrahepatic cholangiocarcinoma.
Zou W; Wang Z; Wang F; Li L; Liu R; Hu M
BMC Cancer; 2021 May; 21(1):608. PubMed ID: 34034689
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive pan-cancer analysis of necroptosis molecules in four gynecologic cancers.
Zheng J; Cai X; Zhang Y; Wang H; Liu L; Tang F; Liu L; Sun Y
BMC Cancer; 2022 Nov; 22(1):1160. PubMed ID: 36357839
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of a Prognostic Model for Esophageal Adenocarcinoma Based on Necroptosis-Related Genes.
Zhang S; Liu S; Lin Z; Zhang J; Lin Z; Fang H; Hu Z
Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553511
[TBL] [Abstract][Full Text] [Related]
18. A novel necroptosis signature for predicting survival in lung adenocarcinoma.
Zang K; Wang M; Zhu X; Yao B; Huang Y
BMC Med Genomics; 2023 Nov; 16(1):305. PubMed ID: 38017445
[TBL] [Abstract][Full Text] [Related]
19. Integrated analysis of necroptosis-related genes for evaluating immune infiltration and colon cancer prognosis.
Yang W; Lu S; Peng L; Zhang Z; Zhang Y; Guo D; Ma F; Hua Y; Chen X
Front Immunol; 2022; 13():1085038. PubMed ID: 36618366
[TBL] [Abstract][Full Text] [Related]
20. A novel three‑miRNA signature predicts survival in cholangiocarcinoma based on RNA‑Seq data.
Cao J; Sun L; Li J; Zhou C; Cheng L; Chen K; Yan B; Qian W; Ma Q; Duan W
Oncol Rep; 2018 Sep; 40(3):1422-1434. PubMed ID: 29956786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]